Bright Minds Biosciences (DRUG) Equity Ratio (2022 - 2026)
Bright Minds Biosciences (DRUG) reported Equity Ratio of 1.17 for Q1 2026, down 26.44% on a YoY basis from 1.59 in Q1 2025, and down 22.19% quarter-over-quarter from 1.5 in Q4 2025.
Bright Minds Biosciences (DRUG) Equity Ratio (2022 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Equity Ratio for 5 years, with the latest figure at 1.17 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 26.44% year-over-year to 1.17; the trailing twelve-month figure through Mar 2026 stood at 1.17 (down 26.44% YoY), and the FY2025 full-year result was 1.46, down 74.84% from the prior year.
- Equity Ratio for Q1 2026 stood at 1.17, down from 1.5 in the prior quarter.
- The five-year high for Equity Ratio was 5.8 in Q3 2024, with the low at 0.87 in Q3 2022.
- Historically, Equity Ratio has averaged 2.48 across 5 years, with a median of 1.52 in 2024.
- Annual changes were most pronounced in 2024 — Equity Ratio jumped 504.97% — and 2025, when it plunged 74.84%.
- Bright Minds Biosciences' Equity Ratio stood at 0.87 in 2022, then jumped by 483.43% to 5.09 in 2023, then sank by 70.05% to 1.52 in 2024, then dropped by 1.27% to 1.5 in 2025, then declined by 22.19% to 1.17 in 2026.
- The last three Equity Ratio figures came in at 1.17 (Q1 2026), 1.5 (Q4 2025), and 1.46 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 191.07 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 0.04 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.42 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 0.79 |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | 1.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 |
| Dec 31, 2025 | 1.50 |
| Sep 30, 2025 | 1.46 |
| Jun 30, 2025 | 1.71 |
| Mar 31, 2025 | 1.59 |
| Dec 31, 2024 | 1.52 |
| Sep 30, 2024 | 5.80 |
| Jun 30, 2024 | 5.58 |
| Dec 31, 2023 | 5.09 |
| Sep 30, 2023 | 0.96 |
| Sep 30, 2022 | 0.87 |